PT Prodia Diagnostic Line Tbk (PRDL), member of Prodia Group, is offering 522.9 million shares to public investors or 30% of enlarged paid-up capital to finance expansion programs and debt payments. This is a small IPO, targeting up to Rp62.75 billion of proceeds, but a litmus test in the volatile stock market. To subscribe please click here
